Agios Presents Updated PYRUKYND® (mitapivat) Data
– Actively Enrolling Phase 3 ENERGIZE and ENERGIZE-T Studies Evaluating PYRUKYND® in Adults with Non-transfusion-dependent and Transfusion-dependent α- or...
Source: globenewswire.com
Page 2 - Real World Setting News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Real World Setting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Real World Setting Today - Breaking & Trending Today
Gilead Sciences, Inc.: Gilead Presents Real-World and Long-Term Data From HIV Research Programs at HIV Glasgow 2022
- New Clinical and Patient-Reported Outcomes in People with HIV on Biktarvy in Observational BICSTaR Study Demonstrate Consistent Efficacy Profile in Real-World Setting - - Long-Term Switch Data
Source: finanznachrichten.de
BIOSOLVE-IV Full-Cohort Two-Year Data Confirm Excellent Safety and Efficacy Profile of Magmaris Resorbable Magnesium Scaffold
Magmaris Scaffold Performs Well in Real World Settings Even in More Complex Patient Groups
Source: dicardiology.com
SARS-CoV-2-specific immune responses elicited by inactivated COVID-19 vaccines
In this study, researchers identified and recruited volunteers who received inactivated COVID-19 vaccines in real-world settings.
Source: news-medical.net
Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic Diseases
Research to be presented on Orencia, deucravacitinib and pipeline assets highlights breadth of data and focus on transforming treatment paradigms for people living with rheumatic diseases Bristol Myers Squibb today announced data from 29 company-sponsored presentations across Orencia, deucravacitinib and pipeline assets will be presented at the American College of Rheumatology Convergence 2021, taking place ...
Source: investingnews.com